Title: Full Text of HR0009
Official Title: 
Number of Sections: 1
Source: versions - Introduced
Media Type: text/html

================================================================================

Section 1:
Full Text of HR0009 ILGA.GOV HR0009 - 104th General Assembly HR0009LRB104 06226 LAW 16261 r1HOUSE RESOLUTION 2    WHEREAS, Juvenile idiopathic arthritis (JIA) is the most 3common childhood chronic rheumatologic disorder; and 4    WHEREAS, JIA has a yearly incidence of 2 to 20 cases per 5100,000 individuals and strikes an estimated total of 294,000 6children in the United States; and 7    WHEREAS, Systemic juvenile idiopathic arthritis (SJIA) is 8a serious subtype of JIA and the most common type of arthritis 9in children and teens, affecting about 10% to 20% of children 10with JIA; and 11    WHEREAS, Systemic means it may affect not only the joints 12but other parts of the body, including the liver, lungs, and 13heart; and 14    WHEREAS, The most serious potential complication of SJIA 15is macrophage activation syndrome (MAS), a massive 16inflammatory response that overwhelms the whole body; and 17    WHEREAS, SJIA, sometimes referred to as Still's disease, 18affects boys and girls equally and can occur at any time during 19childhood, but it most commonly starts at approximately two 20years of age; and   HR0009- 2 -LRB104 06226 LAW 16261 r1    WHEREAS, SJIA differs from other subtypes of JIA because 2it is autoinflammatory rather than autoimmune, more severe, 3and more challenging to diagnose and treat than other types of 4JIA; and 5    WHEREAS, The main cause of SJIA is unknown, but it is 6generally believed to be triggered by something in the 7environment of a child that has a genetic predisposition; and 8    WHEREAS, The symptoms of SJIA are fever, rash, and joint 9pain; a high, recurring fever, often coupled with a rash, is 10one of the first signs of the disease, with this fever usually 11following a pattern in which a child's temperature reaches 103 12degrees Fahrenheit or higher, generally in the evening, and 13then drops within a few hours; and 14    WHEREAS, According to the International League of 15Associations for Rheumatology (ILAR), a diagnosis of SJIA 16requires a high fever for at least two weeks and arthritis, 17such as joint pain and inflammation, in one or more joints for 18at least six weeks; and 19    WHEREAS, There are no specific tests for SJIA; instead, 20doctors have to rely on their experience and expertise as well 21as the child's medical history, a comprehensive physical exam,   HR0009- 3 -LRB104 06226 LAW 16261 r1and laboratory medical equipment to identify the disease; and 2    WHEREAS, While there is no known cure for SJIA, remission 3is possible through early aggressive treatment and non-drug 4therapies; and 5    WHEREAS, Increasing awareness among patients, parents, and 6healthcare providers alike regarding Systemic Juvenile 7Idiopathic Arthritis (SJIA) is a key component in safeguarding 8children's health; therefore, be it 9    RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE 10HUNDRED FOURTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that 11we declare the month of July 2025 as Systemic Juvenile 12Idiopathic Arthritis (SJIA) Awareness Month in the State of 13Illinois; and be it further 14    RESOLVED, That we encourage funding for research 15organizations working towards finding the cause and the cure 16of SJIA in order to prevent this disease and offer successful 17treatment options.


================================================================================

Raw Text:
Full Text of HR0009 ILGA.GOV HR0009 - 104th General Assembly HR0009LRB104 06226 LAW 16261 r1HOUSE RESOLUTION 2    WHEREAS, Juvenile idiopathic arthritis (JIA) is the most 3common childhood chronic rheumatologic disorder; and 4    WHEREAS, JIA has a yearly incidence of 2 to 20 cases per 5100,000 individuals and strikes an estimated total of 294,000 6children in the United States; and 7    WHEREAS, Systemic juvenile idiopathic arthritis (SJIA) is 8a serious subtype of JIA and the most common type of arthritis 9in children and teens, affecting about 10% to 20% of children 10with JIA; and 11    WHEREAS, Systemic means it may affect not only the joints 12but other parts of the body, including the liver, lungs, and 13heart; and 14    WHEREAS, The most serious potential complication of SJIA 15is macrophage activation syndrome (MAS), a massive 16inflammatory response that overwhelms the whole body; and 17    WHEREAS, SJIA, sometimes referred to as Still's disease, 18affects boys and girls equally and can occur at any time during 19childhood, but it most commonly starts at approximately two 20years of age; and   HR0009- 2 -LRB104 06226 LAW 16261 r1    WHEREAS, SJIA differs from other subtypes of JIA because 2it is autoinflammatory rather than autoimmune, more severe, 3and more challenging to diagnose and treat than other types of 4JIA; and 5    WHEREAS, The main cause of SJIA is unknown, but it is 6generally believed to be triggered by something in the 7environment of a child that has a genetic predisposition; and 8    WHEREAS, The symptoms of SJIA are fever, rash, and joint 9pain; a high, recurring fever, often coupled with a rash, is 10one of the first signs of the disease, with this fever usually 11following a pattern in which a child's temperature reaches 103 12degrees Fahrenheit or higher, generally in the evening, and 13then drops within a few hours; and 14    WHEREAS, According to the International League of 15Associations for Rheumatology (ILAR), a diagnosis of SJIA 16requires a high fever for at least two weeks and arthritis, 17such as joint pain and inflammation, in one or more joints for 18at least six weeks; and 19    WHEREAS, There are no specific tests for SJIA; instead, 20doctors have to rely on their experience and expertise as well 21as the child's medical history, a comprehensive physical exam,   HR0009- 3 -LRB104 06226 LAW 16261 r1and laboratory medical equipment to identify the disease; and 2    WHEREAS, While there is no known cure for SJIA, remission 3is possible through early aggressive treatment and non-drug 4therapies; and 5    WHEREAS, Increasing awareness among patients, parents, and 6healthcare providers alike regarding Systemic Juvenile 7Idiopathic Arthritis (SJIA) is a key component in safeguarding 8children's health; therefore, be it 9    RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE 10HUNDRED FOURTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that 11we declare the month of July 2025 as Systemic Juvenile 12Idiopathic Arthritis (SJIA) Awareness Month in the State of 13Illinois; and be it further 14    RESOLVED, That we encourage funding for research 15organizations working towards finding the cause and the cure 16of SJIA in order to prevent this disease and offer successful 17treatment options.